Robust isolation protocol for mouse leukocytes from blood and liver resident cells for immunology research
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304063 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Dorien De Pooter und 11 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium. Hauptthemen laut MEDLINE: Liver, Leukocytes. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Research on liver-related conditions requires a robust and efficient method to purify viable hepatocytes, lymphocytes and all other liver resident cells, such as Kupffer or liver sinusoidal endothelial cells. Here we describe a novel purification method using liver enzymatic digestion, followed by a downstream optimized purification. Using this enzymatic digestion protocol, the resident liver cells as well as viable hepatocytes could be captured, compared to the classical mechanical liver disruption method. Moreover, single-cell RNA-sequencing demonstrated higher quality lymphocyte data in downstream analyses after the liver enzymatic digestion, allowing for studying of immunological responses or changes. In order to also understand the peripheral immune landscape, a protocol for lymphocyte purification from mouse systemic whole blood was optimized, allowing for efficient removal of red blood cells. The combination of microbeads and mRNA blockers allowed for a clean blood sample, enabling robust single-cell RNA-sequencing data. These two protocols for blood and liver provide important new methodologies for liver-related studies such as NASH, hepatitis virus infections or cancer research but also for immunology where high-quality cells are indispensable for further downstream assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, Beerse, Belgium.
- Charles River Laboratories, Beerse, Belgium.
- Discovery Technologies & Molecular Pharmacology, Therapeutics Discovery, Janssen Research and Development, Beerse, Belgium.
- Infectious Diseases Discovery, Infectious Diseases Therapeutic Area, Janssen Research and Development, California, Brisbane, United States of America.
ORCID-Profile: Isabelle Bergiers, Nádia Conceição-Neto, Wim Pierson
Zitieren
APA
De Pooter, D., De Clerck, B., Dockx, K., De Santis, D., Sauviller, S., Dehertogh, P., Beyens, M., Bergiers, I., Nájera, I., Van Gulck, E., Conceição-Neto, N., & Pierson, W. (2024). Robust isolation protocol for mouse leukocytes from blood and liver resident cells for immunology research. PLOS ONE. https://doi.org/10.1371/journal.pone.0304063
Vancouver
De Pooter D, De Clerck B, Dockx K, De Santis D, Sauviller S, Dehertogh P, et al. Robust isolation protocol for mouse leukocytes from blood and liver resident cells for immunology research. PLOS ONE. 2024. doi:10.1371/journal.pone.0304063
BibTeX
@article{DePooter2024,
author = {De Pooter, Dorien and De Clerck, Ben and Dockx, Koen and De Santis, Domenica and Sauviller, Sarah and Dehertogh, Pascale and Beyens, Matthias and Bergiers, Isabelle and Nájera, Isabel and Van Gulck, Ellen and Conceição-Neto, Nádia and Pierson, Wim},
title = {Robust isolation protocol for mouse leukocytes from blood and liver resident cells for immunology research},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304063}
}
EUVIMED